# US 2012/0083488 A1 · Tetracyclic compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0083488 A1
- Document ID: US20120083488A1
- Status: Published application
- Kind: A1
- Application number: 13/377,300
- Filed: 2010-06-09
- Published: 2012-04-05
- Earliest claimed: 2009-06-10
- Assignees: Chugai Seiyaku Kabushiki Kaisha
- Inventors: Kazutomo Kinoshita; Kohsuke Asoh; Noriyuki Furuichi; Toshiya Ito; Hatsuo Kawada; Nobuya Ishii; Hiroshi Sakamoto; WooSang Hong; MinJeong Park; Yoshiyuki Ono; Yashuharu Kato; Kenji Morikami; Takashi Emura; Nobuhiro Oikawa
- Web page: https://patentgrep.com/patent/US20120083488A1

## CPC

- C07D 209/58: [b]- or [c]-condensed
- A61K 31/404: Indoles, e.g. pindolol
- A61K 31/4178: not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A61K 31/4439: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
- A61K 31/454: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A61K 31/496: Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A61K 31/506: not condensed and containing further heterocyclic rings
- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- A61K 31/541: Non-condensed thiazines containing further heterocyclic rings
- A61K 31/7056: containing five-membered rings with nitrogen as a ring hetero atom
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/24: Antidepressants
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 35/00: Antineoplastic agents
- A61P 35/02: specific for leukemia
- A61P 35/04: specific for metastasis
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 209/56: Ring systems containing three or more rings
- C07D 209/88: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D 307/77: ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D 307/78: Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D 307/92: Naphthofurans; Hydrogenated naphthofurans
- C07D 333/50: condensed with carbocyclic rings or ring systems
- C07D 333/52: Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D 333/76: Dibenzothiophenes
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 401/14: containing three or more hetero rings
- C07D 403/04: directly linked by a ring-member-to-ring-member bond
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 405/14: containing three or more hetero rings
- C07D 409/12: linked by a chain containing hetero atoms as chain links
- C07D 413/14: containing three or more hetero rings
- C07D 471/04: Ortho-condensed systems
- C07D 471/10: Spiro-condensed systems
- C07D 491/107: with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07F 7/0834: {Compounds having one or more O-Si linkage (for compounds with C-O-Si linkages see C07F7/18)}
- C07H 15/26: Acyclic or carbocyclic radicals, substituted by hetero rings
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

A compound represented by the general Formula (I) below, or a salt or solvate thereof, which is useful as an ALK inhibitor, and is useful for prophylaxis or treatment of a disease accompanied by abnormality in ALK, for example, cancer, cancer metastasis, depression or cognitive function disorder: (meanings of the symbols that are included in the formula are as given in the specification).

## Claims

### Claim 1

A compound or salt or solvate thereof represented by Formula (I):
wherein,
A1, A2, A3, A4, A7, A8, A9 and A10 all represent C, or any one of A2, A3, A4, A7, A8 and A9 represents N (with the proviso that, when it represents N, no substituent group exists therefor) and the remainings represent C;
A5 is selected from NR5, O and S;
R1 and R10 each independently represent [1] a hydrogen atom, [2] a cyano group, [3] a halogen atom or [4] a 4- to 10-membered heterocycloalkyl group which may be substituted by 4- to 10-membered heterocycloalkyl group(s);
R2 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a C1-8 alkyl group,
(3) a C2-8 alkenyl group,
(4) a C2-8 alkynyl group,
(5) a cyano group,
(6) a halogen atom,
(7) a (C1-8 alkyl)m2-amino group which may be substituted by C1-8 alkylsulfonyl group(s),
m2: 0˜2, and
(8) a nitro group;
R3 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a C1-8 alkyl group which may be substituted by [1] halogen atom(s), [2] hydroxy group(s) or [3] C1-8 alkoxy group(s),
(3) a C6-10 aryl group,
(4) a cyano group,
(5) a C1-8 alkanoyl group which may be substituted by C6-10 aryl group(s),
(6) a (C1-8 alkyl)m3a-aminocarbonyl group which may be substituted by one or more R3A,
R3A: [1] a C6-10 aryl group, [2] a C1-8 alkoxy group, [3] a 5- to 14-membered heteroaryl group, or [4] a C6-10 arylsulfonyl group,
m3a: 0˜2,
(7) a hydroxycarbonyl group,
(8) a C1-8 alkoxycarbonyl group which may be substituted by [1] hydroxy group(s) or [2] C1-8 alkoxy group(s),
(9) a halogen atom,
(10) a (C1-8 alkyl)m3b-amino group which may be substituted by C6-10 aryl group(s),
m3b: 0˜2,
(11) a C1-8 alkylcarbonyl (C0-8 alkyl)amino group which may be substituted by [1] C6-10 aryl group(s) or [2] C6-10 aryloxy group(s),
(12) a C6-10 arylcarbonyl (C0-8 alkyl)amino group which may be substituted by C1-8 alkyl group(s) which may be substituted by halogen atom(s),
(13) a (C1-8 alkyl)m3caminocarbonyl (C0-8 alkyl)amino group which may be substituted by C6-10 aryl group(s),
m3c: 0˜2,
(14) a nitro group,
(15) a hydroxy group,
(16) a C1-8 alkoxy group which may be substituted by one or more R3B,
R3B: [1] a hydroxy group, [2] a C1-8 alkoxy group, [3] a C6-10 aryl (C0-8 alkyl)aminocarbonyl group, [4] a (C1-8 alkyl)m3d-amino group, or [5] a halogen atom,
m3d: 0˜2,
(17) a 4- to 10-membered heterocycloalkyloxy group,
(18) a 5- to 14-membered heteroaryloxy group,
(19) a (C1-8 alkyl)m3c-aminocarbonyloxy group which may be substituted by C6-10 aryl group(s)
m3e: 0˜2,
(20) a 4- to 10-membered nitrogen-containing heterocycloalkylcarbonyl group,
(21) a C1-8 alkylsulfonyloxy group which may be substituted by halogen atom(s),
(22) a C1-8 alkylthio group,
(23) a C1-8 alkylsulfonyl group which may be substituted by C6-10 aryl group(s),
(24) a 5- to 14-membered heteroaryl group which may be substituted by C1-8 alkyl group(s) which may be substituted by C1-8 alkoxy group(s),
(25) a C1-8 alkoxycarbonyl (C0-8 alkyl)amino group which may be substituted by C1-8 alkoxy group(s),
(26) a C6-10 aryloxycarbonyl (C0-8 alkyl)amino group which may be substituted by C1-8 alkyl group(s) which may be substituted by halogen atom(s),
(27) a C6-10 aryl (C0-8 alkyl)aminocarbonyl (C0-8 alkyl)amino group which may be substituted by one or more R3C,
R3C: [1] a C1-8 alkyl group which may be substituted by halogen atom(s), or [2] a C1-8 alkoxy group,
(28) a C3-8 cycloalkyl (C0-8 alkyl)aminocarbonyloxy group, and
(29) a C6-10 aryl (C0-8 alkyl)aminocarbonyloxy group which may be substituted by substituent(s) selected from the group consisting of [1] a C1-8 alkyl group and [2] a C1-8 alkoxy group;
R4 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a C1-8 alkyl group which may be substituted by halogen atom(s),
(3) a C2-8 alkenyl group,
(4) a C2-8 alkynyl group,
(5) a C3-8 cycloalkyl group,
(6) a cyano group,
(7) an aminocarbonyl group,
(8) a (C1-8 alkyl)m4a-aminocarbonyl group,
m4a: 1˜2,
(9) a hydroxycarbonyl group,
(10) a C1-8 alkoxycarbonyl group,
(11) a halogen atom,
(12) a (C1-8 alkyl)m4b-amino group,
m4b: 0˜2,
(13) a hydroxy group, and
(14) a C1-8 alkoxy group which may be substituted by hydroxy group(s);
R5 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a C1-8 alkyl group which may be substituted by one or more R5A,
R5A: [1] a hydroxycarbonyl group, [2] a C1-8 alkoxycarbonyl group, [3] a hydroxy group, [4] a C1-8 alkoxy group, [5] a (C1-8 alkyl)m5-amino group, [6] a C6-10 aryl group, or [7] a C1-8 alkylthio group,
m5: 0˜2,
(3) a C2-8 alkenyl group,
(4) a C2-8 alkynyl group,
(5) a C3-8 cycloalkyl group, and
(6) a C1-8 alkylsulfonyl group;
R6 and R6′ are each independently selected from the group consisting of:
(1) a C1-8 alkyl group which may be substituted by halogen atom(s),
(2) a C2-8 alkenyl group, and
(3) a C2-8 alkynyl group; or
R6 and R6′ are taken together with the carbon atoms to which they are bound to form:
(4) a C3-8 cycloalkyl group, or
(5) a 4- to 10-membered heterocycloalkyl group which may be substituted by C1-8 alkyl C6-10 aryl sulfonyl group(s) which may be substituted by C1-8 alkyl group(s);
R7 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a halogen atom,
(3) a C1-8 alkoxy group which may be substituted by one or more R7A,
R7A: [1] a (C1-8 alkyl)m7a-amino group, [2] a hydroxy, [3] a 4- to 10-membered heterocycloalkyl group which may be substituted by C1-8 alkyl group(s),
m7a: 0˜2,
(4) a C1-8 alkylsulfonyl group,
(5) a nitro group, and
(6) a hydroxyl group;
R8 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a C1-8 alkyl group which may be substituted by one or more R8A,
R8A: [1] a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R8A1, [2] a (C1-8 alkyl)m8a-amino group which may be substituted by a halogen atom, or [3] a hydroxy group,
m8a:0˜2,
R8A1: [1] a C1-8 alkyl group, [2] a C1-8 alkylsulfonyl group, [3] a (C1-8 alkyl)m8b-aminosulfonyl group, [4] an oxo group, [5] a C1-8 alkoxycarbonyl, or [6] a C1-8 alkoxycarbonyl (C0-8 alkyl)aminosulfonyl,
m8b: 0˜2,
(3) a C2-8 alkenyl group,
(4) a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R8B,
R8B:
<1> a C1-8 alkyl group which may be substituted by one or more R8B1,
<2> a C2-8 alkeynyl group,
<3> a C2-8 alkynyl group,
<4> a C3-8 cycloalkyl group which may be substituted by [1] cyano group(s) or [2] C1-8 alkyl group(s),
<5> a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R8B2,
<6> a C1-8 alkoxy group which may be substituted by substituent(s) selected from the group consisting of [1] a C1-8 alkoxy group and [2] a C3-8 cycloalkyl group,
<7> a C1-8 alkoxycarbonyl group,
<8> a C1-8 alkylsulfonyl group,
<9> a 5- to 14-membered heteroarylsulfonyl group,
<10> an oxo group,
<11> a cyano group,
<12> a C1-8 alkanoyl group which may be substituted by one or more R8B3,
<13> a C3-8 cycloalkylcarbonyl group,
<14> a (C1-8 alkyl)m8c-aminosulfonyl group,
<15> a C1-8 alkylsulfonyl (C0-8 alkyl)amino group,
<16> a (C1-8 alkyl)m8d-amino group which may be substituted by one or more R8B4,
<17> a hydroxy group,
<18> a (C1-8 alkyl)m8c-aminocarbonyl group, or
<19> a C1-8 alkoxycarbonyl (C0-8 alkyl)amino group
m8c: 0˜2
m8d: 0˜2
m8e: 0˜2
R8B1: [1] a C3-8 cycloalkyl group, [2] a hydroxy group, or [3] a C1-8 alkoxy group(s),
R8B2: [1] a halogen atom, [2] a C1-8 alkyl group, [3] an oxo group, [4] a hydroxy group, or [5] a deuterium atom,
R8B3: a (C1-8 alkyl)m8f-amino group,
m8f: 0˜2,
R8B4: [1] a C3-8 cycloalkyl group, or [2] a hydroxy group,
(5) a 5- to 14-membered heteroaryl group which may be substituted by a C1-8 alkyl group,
(6) a (C1-8 alkyl)m8g-aminocarbonyl group which may be substituted by one or more R8C,
m8g: 0˜2,
R8C: [1] a hydroxy group, [2] a (C1-8 alkyl)m8h-amino group which may be substituted by substituent(s) selected from the group consisting of <1> a (C1-8 alkyl)m8i-aminosulfonyl group, <2> a C1-8 alkylsulfonyl group, <3> a C1-8 alkoxycarbonyl group and <4> a C1-8 alkoxycarbonyl(C0-8 alkyl)aminosulfonyl group, [3] a C1-8 alkylsulfonyl group, or [4] a C1-8 alkoxy group which may be substituted by a hydroxy group,
m8h: 0˜2,
m8i: 0˜2,
(7) a 4- to 10-membered heterocycloalkyl (C0-8 alkyl)aminocarbonyl group which may be substituted by oxo group(s),
(8) a 4- to 10-membered nitrogen-containing heterocycloalkylcarbonyl group which may be substituted by one or more R8D,
R8D: [1] a C1-8 alkyl group which may be substituted by one or more R8D1, [2] a hydroxy group, [3] a C1-8 alkylsulfonyl group, or [4] a C1-8 alkoxycarbonyl group,
R8D1: [1] a hydroxy group, or [2] a C1-8 alkoxy group,
(9) a hydroxycarbonyl group,
(10) a C0-8 alkoxy (C0-8 alkyl)aminocarbonyl group which may be substituted by hydroxy group(s),
(11) a halogen atom,
(12) a (C1-8 alkyl)m8j-amino group which may be substituted by one or more R8H,
m8j: 0˜2,
R8H: [1] a hydroxy group, or [2] a 4- to 10-membered heterocycloalkyl group,
(13) a hydroxyl group,
(14) a C1-8 alkoxy group which may be substituted by one or more R8E,
R8E:
<1> a hydroxy group,
<2> halogen atom,
<3> a hydroxycarbonyl group,
<4> a C1-8 alkoxycarbonyl group,
<5> a 4- to 10-membered nitrogen-containing heterocycloalkylcarbonyl group which may be substituted by one or more R8E1,
<6> a (C1-8 alkyl)m8k1-amino group which may be substituted by one or more R8E2,
m8k1: 0˜2,
<7> a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R8E3,
<8> a 5- to 14-membered heteroaryl group,
<9> a (C1-8 alkyl)m8k2-aminocarbonyl group which may be substituted by one or more R8E6,
m8k2: 0˜2,
<10> a C1-8 alkoxy group which may be substituted by one or more R8E7,
<11> a C1-8 alkylthio group,
<12> a C1-8 alkylsulfinyl group,
<13> a C1-8 alkylsulfonyl group,
R8E1:
<1> a C1-8 alkoxycarbonyl group,
<2> a C1-8 alkanoyl group,
<3> a C1-8 alkylsulfonyl group,
<4> a (C1-8 alkyl)m8k3-aminosulfonyl group,
m8k3: 0˜2, or
<5> a 4- to 10-membered heterocycloalkyl group,
R8E2:
<1> a hydroxy group,
<2> a C1-8 alkoxycarbonyl group which may be substituted by halogen atom(s),
<3> a C3-8 cycloalkyl group which may be substituted by C1-8 alkyl group(s) which may be substituted by hydroxy group(s),
<4> a C1-8 alkanoyl group which may be substituted by substituent(s) selected from the group consisting of [1] a (C1-8 alkyl)m8k4-amino group and [2] a halogen atom(s),
m8k4: 0˜2,
<5> a (C1-8 alkyl)m8k5-aminocarbonyl group,
m8k5: 0˜2,
<6> a C1-8 alkylsulfonyl group,
<7> a 4- to 10-membered nitrogen-containing heterocycloalkylsulfonyl group which may be substituted by C1-8 alkyl group(s),
<8> a (C1-8 alkyl)m8k6-aminosulfonyl group which may be substituted by C1-8 alkoxycarbonyl group(s),
m8k6: 0˜2, or
R8E3:
<1> a C1-8 alkyl group which may be substituted by substituent(s) selected from the group consisting of [1] a hydroxy group and [2] a C1-8 alkylcarbonyloxy group,
<2> a C1-8 alkylcarbonyloxy group,
<3> a hydroxy group,
<4> a C3-8 cycloalkyl group,
<5> a C1-8 alkoxy group,
<6> a C1-8 alkoxycarbonyl group,
<7> a C1-8 alkylsulfonyl group,
<8> a (C1-8 alkyl)m8k8-aminocarbonyl group
m8k8: 0˜2,
<9> a C1-8 alkanoyl group which may be substituted by hydroxy group(s),
<10> an oxo group, or
<11> a 4- to 10-membered heterocycloalkyl group which may be substituted by substituent(s) selected from the group consisting of [1] a C1-8 alkanoyl group, [2] a C1-8 alkoxycarbonyl group and [3] a C1-8 alkylsulfonyl group,
R8E6:
<1> a C2-8 alkenylcarbonyloxy group,
<2> a hydroxy group,
<3> a cyano group,
<4> a (C1-8 alkyl)m8k9-amino group which may be substituted by hydroxy group(s)
m8k9: 0˜2,
<5> a C1-8 alkoxy group which may be substituted by hydroxy group(s),
<6> a C1-8 alkylcarbonyloxy group,
<7> a 4- to 10-membered heterocycloalkyl group which may be substituted by C1-8 alkyl group(s), or
<8> a 5- to 14-membered heteroaryl group,
R8E7:
<1> a hydroxy group, or
<2> a C1-8 alkoxy group which may be substituted by hydroxy group(s),
(15) a 4- to 10-membered heterocycloalkyloxy group which may be substituted by one or more R8F,
R8F:
<1> a C1-8 alkyl group which may be substituted by one or more R8F1,
<2> a C3-8 cycloalkyl group,
<3> a C1-8 alkanoyl group which may be substituted by halogen atom(s),
<4> a C1-8 alkylcarbonyloxy group,
<5> a C1-8 alkoxycarbonyl group,
<6> a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R8F2,
<7> a C1-8 alkyl sulfonyl group,
<8> a hydroxy group, or
[9] a C6-10 aryl group,
R8F1: [1] a hydroxy group, [2] a C1-8 alkoxy group, or [3] a halogen atom,
R8F2: [1] a 4- to 10-membered heterocycloalkyl group, [2] a C1-8 alkoxycarbonyl group, or [3] a C1-8 alkylsulfonyl group,
(16) a 5- to 14-membered heteroaryloxy group,
(17) a 4- to 10-membered heterocycloalkylcarbonyloxy group,
(18) a (C1-8 alkyl)m8l1-aminosulfonyloxy group,
m8l1: 0˜2,
(19) a C1-8 alkyl thio group which may be substituted by [1] (C1-8 alkyl)m8l2-amino group(s), [2] hydroxy group(s) or [3] hydroxycarbonyl group(s),
m8l2: 0˜2,
(20) a C1-8 alkylsulfonyl group which may be substituted by one or more R8G,
R8G: [1] a hydroxycarbonyl group, [2] a hydroxy group, or [3] a (C1-8 alkyl)m8l3-amino group,
m8l3: 0˜2,
(21) a 4- to 10-membered nitrogen-containing heterocycloalkylsulfonyloxy group which may be substituted by C1-8 alkyl group(s),
(22) a C2-8 alkenyloxy group, and
(23) a C1-8 alkylsulfonyloxy group which may be substituted by halogen atom(s);
R9 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a C1-8 alkyl group which may be substituted by one or more R9A,
R9A: [1] a C3-8 cycloalkyl group, [2] a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R9A1, [3] a hydroxy group, [4] a C1-8 alkoxy group, or [5] a hydroxycarbonyl group,
R9A1: [1] a C1-8 alkyl group, [2] a C3-8 cycloalkyl group, or [3] a 4- to 10-membered heterocycloalkyl group,
(3) a C2-8 alkenyl group which may be substituted by one or more R9B,
R9B: [1] a (C1-8 alkyl)m9a-amino group, [2] a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more group R9B1,
R9B1: [1] a C3-8 cycloalkyl group, or [2] a 4- to 10-membered heterocycloalkyl group,
m9a: 0˜2,
(4) a C2-8 alkynyl group which may be substituted by one or more R9C,
R9C: [1] a C1-8 alkoxy group, [2] a (C1-8 alkyl)m9b-amino group which may be substituted by C6-10 aryl group(s), [3] a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R9C1, [4] a C3-8 cycloalkyl group, [5] a hydroxy group, [6] a hydroxycarbonyl group, or [7] a C1-8 alkyloxycarbonyl group,
m9b: 0˜2,
R9C1: [1] a C3-8 cycloalkyl group, [2] a 4- to 10-membered heterocycloalkyl group, or [3] an oxo group,
(5) a C3-8 cycloalkyl group,
(6) a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R9D,
R9D: [1] a C1-8 alkyl group which may be substituted by 4- to 10-membered heterocycloalkyl group(s), [2] a C3-8 cycloalkyl group, [3] a 4- to 10-membered heterocycloalkyl group, or [4] a C1-6 alkylsulfonyl group, or [5] a C1-8 alkoxycarbonyl group,
(7) a C6-10 aryl group which may be substituted by one or more R9E,
R9E: [1] a halogen atom, [2] a hydroxy group, [3] a hydroxycarbonyl group, or [4] a C1-8 alkyl group which may be substituted by hydroxy group(s), or [5] a C1-8 alkoxy group,
(8) a 5- to 14-membered heteroaryl group which may be substituted by C1-8 alkyl group(s),
(9) a cyano group,
(10) a C1-8 alkanoyl group,
(11) a 4- to 10-membered nitrogen-containing heterocycloalkylcarbonyl group which may be substituted by C1-8 alkyl group(s),
(12) a halogen atom,
(13) a (C1-8 alkyl)m9c-amino group which may be substituted by one or more R9F,
m9c: 0˜2,
(14) a C1-8 alkylcarbonyl(C0-8 alkyl)amino group which may be substituted by (C1-8 alkyl)m9d-amino group(s),
m9d: 0˜2,
(15) a C1-8 alkylsulfonyl(C0-8 alkyl)amino group,
(16) a (C1-8 alkyl)m9c-aminosulfonyl(C0-8 alkyl)amino group,
m9e: 0˜2,
(17) a nitro group,
(18) a hydroxy group,
(19) a C1-8 alkoxy group which may be substituted by one or more R9G,
R9G: [1] a hydroxy group, [2] a hydroxycarbonyl group, [3] a C6-10 aryl group which may be substituted by C1-8 alkoxy group(s), [4] a (C1-8 alkyl)m9g1-amino group, [5] a C1-8 alkoxy group which may be substituted by one or more R9G1, [6] a 5- to 14-membered heteroaryl group, or [7] a 4- to 10-membered heterocycloalkyloxy group which may be substituted by C1-8 alkyl group(s),
m9g1: 0˜2,
R9G1: [1] a C1-8 alkoxy group, or [2] a hydroxycarbonyl group,
(20) a 4- to 10-membered heterocycloalkyloxy group which may be substituted by [1] 4- to 10-membered heterocycloalkyl group(s), or [2] C1-8 alkoxycarbonyl group(s),
(21) a C1-8 alkylsulfonyloxy group which may be substituted by halogen atom(s),
(22) a C1-8 alkylthio group which may be substituted by (C1-8 alkyl)m9f-amino group(s),
m9f: 0˜2,
(23) a C1-8 alkylsulfonyl group which may be substituted by (C1-8 alkyl)m9g-amino group(s),
m9g: 0˜2,
(24) a (C1-8 alkyl)m9h-aminosulfonyl group,
m9h: 0˜2,
(25) a 4- to 10-membered nitrogen-containing heterocycloalkylsulfonyl group which may be substituted by C1-8 alkyl group(s), and
(26) a hydroxycarbonyl group.

### Claim 2 (depends on 1)

The compound according to claim 1, or a salt or solvate thereof, wherein R3 is a cyano group or a halogen atom.

### Claim 3 (depends on 1)

The compound according to claim 1, or a salt or solvate thereof, wherein A5 is NR5 and R5 is a hydrogen atom.

### Claim 4 (depends on 1)

The compound according to claim 1, or a salt or solvate thereof, wherein all of the A1, A2, A3, A4, A7, A8, A9 and A10 are a carbon atom.

### Claim 5 (depends on 1)

The compound according to claim 1, or a salt or solvate thereof, wherein:
A1, A2, A3, A4, A7, A8, A9 and A10 all represent C, or any one of A2, A3, A4, A7, A8 and A9 represents N (with the proviso that, when it represents N, no substituent group exists therefor) and the remainings represent C;
A5 is selected from NR5, O and S;
R1 represents [1] a hydrogen atom, [2] a cyano group, or [3] a halogen atom;
R2 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a C1-8 alkyl group,
(3) a cyano group,
(4) a halogen atom, and
(5) a (C1-8 alkyl)m2-amino group which may be substituted by C1-8 alkylsulfonyl group(s),
m2: 0˜2;
R3 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a C1-8 alkyl group which may be substituted by halogen atom(s),
(3) a cyano group,
(4) a (C1-8 alkyl)m3a-aminocarbonyl group which may be substituted by one or more R3A,
R3A: [1] a C6-10 aryl group, [2] a C1-8 alkoxy group, [3] a 5- to 14-membered heteroaryl group, or [4] a C6-10 aryl sulfonyl group,
m3a: 0˜2,
(5) a hydroxycarbonyl group,
(6) a C1-8 alkoxycarbonyl group which may be substituted by hydroxy group(s),
(7) a halogen atom,
(8) a (C1-8 alkyl)m3b-amino group which may be substituted by C6-10 aryl group(s),
m3b: 0˜2,
(9) a C1-8 alkylcarbonyl (C0-8 alkyl)amino group which may be substituted by [1] C6-10 aryl group(s) or [2] C6-10 aryloxy group(s),
(10) a C6-10 arylcarbonyl (C0-8 alkyl)amino group which may be substituted by C1-8 alkyl group(s) which may be substituted by halogen atom(s),
(11) a nitro group,
(12) a hydroxy group,
(13) a C1-8 alkoxy group which may be substituted by one or more R3B,
R3B: [1] a hydroxy group, [2] a C1-8 alkoxy group, [3] a C6-10 aryl (C0-8 alkyl)aminocarbonyl group, [4] a (C1-8 alkyl)m3d-amino group, or [5] a halogen atom,
m3d: 0˜2,
(14) a 4- to 10-membered heterocycloalkyloxy group,
(15) a 5- to 14-membered heteroaryloxy group,
(16) a (C1-8 alkyl)m3e-aminocarbonyloxy group which may be substituted by C6-10 aryl group(s),
m3e: 0˜2
(17) a 4- to 10-membered nitrogen-containing heterocycloalkylcarbonyl group,
(18) a C1-8 alkylthio group,
(19) a 5- to 14-membered heteroaryl group which may be substituted by C1-8 alkyl group(s) which may be substituted by C1-8 alkoxy group(s),
(20) a C1-8 alkoxycarbonyl (C0-8 alkyl)amino group which may be substituted by C1-8 alkoxy group(s),
(21) a C6-10 aryloxycarbonyl (C0-8 alkyl)amino group which may be substituted by C1-8 alkyl group(s) which may be substituted by halogen atom(s),
(22) a C6-10 aryl (C0-8 alkyl)aminocarbonyl (C0-8 alkyl)amino group which may be substituted by C1-8 alkoxy group(s),
(23) a C3-8 cycloalkyl (C0-8 alkyl)aminocarbonyloxy group, and
(24) a C6-10 aryl (C0-8 alkyl)aminocarbonyloxy group which may be substituted by substituent(s) selected from the group consisting of [1] a C1-8 alkyl group and [2] a C1-8 alkoxy group;
R4 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a C1-8 alkyl group which may be substituted by halogen atom(s),
(3) a C3-8 cycloalkyl group,
(4) a cyano group,
(5) an aminocarbonyl group,
(6) a hydroxycarbonyl group,
(7) a halogen atom,
(8) a (C1-8 alkyl)m4b-amino group,
m4b: 0˜2,
(9) a hydroxy group, and
(10) a C1-8 alkoxy group which may be substituted by hydroxy group(s);
R5 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a C1-8 alkyl group which may be substituted by one or more R5A,
R5A: [1] a hydroxycarbonyl group, [2] a C1-8 alkoxycarbonyl group, [3] a hydroxy group, [4] a C1-8 alkoxy group, [5] a (C1-8 alkyl)m5-amino group, or [6] a C1-8 alkylthio group,
m5: 0˜2, and
(3) a C1-8 alkylsulfonyl group;
R6 and R6′ are each independently:
(1) a C1-8 alkyl group, or
R6 and R6′ are taken together with the carbon atoms to which they are bound to form,
(2) a C3-8 cycloalkyl group, or
(3) a 4- to 10-membered heterocycloalkyl group;
R7 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a halogen atom, and
(3) a C1-8 alkoxy group which may be substituted by one or more R7A,
R7A: [1] a (C1-8 alkyl)m7a-amino group, or [2] a hydroxy group,
m7a:0˜2;
R8 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a C1-8 alkyl group which may be substituted by one or more R8A,
R8A: [1] a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R8A1, [2] a (C1-8 alkyl)m8a-amino group which may be substituted by a halogen atom, or [3] a hydroxy group,
m8a:0˜2,
R8A1: [1] a C1-8 alkyl group, [2] a C1-8 alkylsulfonyl group, [3] a (C1-8 alkyl)m8b-aminosulfonyl group, or [4] an oxo group,
m8b: 0˜2,
(3) a C2-8 alkenyl group,
(4) a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R8B,
R8B:
<1> a C1-8 alkyl group which may be substituted by one or more R8B1,
<2> a C2-8 alkynyl group,
<3> a C3-8 cycloalkyl group which may be substituted by [1] cyano group(s) or [2] C1-8 alkyl group(s),
<4> a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R8B2,
<5> a C1-8 alkoxy group which may be substituted by substituent(s) selected from the group consisting of [1] a C1-8 alkoxy group and [2] a C3-8 cycloalkyl group,
<6> a C1-8 alkylsulfonyl group,
<7> an oxo group,
<8> a cyano group,
<9> a C1-8 alkanoyl group which may be substituted by one or more R8B3,
<10> a C3-8 cycloalkylcarbonyl group,
<11> a (C1-8 alkyl)m8c-aminosulfonyl group,
<12> a C1-8 alkylsulfonyl (C0-8 alkyl)amino group,
<13> a (C1-8 alkyl)m8d-amino group which may be substituted by one or more R8B4,
<14> a hydroxy group, or
<15> a (C1-8 alkyl)m8e-aminocarbonyl group,
m8c: 0˜2,
m8d: 0˜2,
m8e: 0˜2,
R8B1: [1] a C3-8 cycloalkyl group, [2] a hydroxy group, or [3] C1-8 alkoxy group which may be substituted by C1-8 alkoxy group(s),
R8B2: [1] a halogen atom, [2] a C1-8 alkyl group, [3] an oxo group, or [4] a hydroxy group,
R8B3: a (C1-8 alkyl)m8f-amino group,
m8f: 0˜2,
R8B4: [1] a C3-8 cycloalkyl group, or [2] a hydroxy group,
(5) a 5- to 14-membered heteroaryl group which may be substituted by a C1-8 alkyl group,
(6) a (C1-8 alkyl)m8g-aminocarbonyl group which may be substituted by one or more R8C,
m8g: 0˜2,
R8C:[1] a hydroxy group, [2] a (C1-8 alkyl)m8h-amino group which may be substituted by substituent(s) selected from the group consisting of <1> a (C1-8 alkyl)m8i-aminosulfonyl group and <2> a C1-8 alkylsulfonyl group, or [3] a C1-8 alkylsulfonyl group,
m8h: 0˜2,
m8i: 0˜2,
(7) a 4- to 10-membered heterocycloalkyl (C0-8 alkyl)aminocarbonyl group which may be substituted by oxo group(s),
(8) a 4- to 10-membered nitrogen-containing heterocycloalkylcarbonyl group which may be substituted by one or more R8D,
R8D: [1] a C1-8 alkyl group which may be substituted by one or more R8D1, [2] a hydroxy group, or [3] a C1-8 alkylsulfonyl group,
R8D1: [1] a hydroxy group, or [2] a C1-8 alkoxy group,
(9) a hydroxycarbonyl group,
(10) a C0-8 alkoxy (C0-8 alkyl)aminocarbonyl group which may be substituted by hydroxy group(s),
(11) a halogen atom,
(12) a (C1-8 alkyl)m8j-amino group which may be substituted by 4- to 10-membered heterocycloalkyl group(s),
m8j: 0˜2,
(13) a hydroxyl group,
(14) a C1-8 alkoxy group which may be substituted by one or more R8E,
R8E:
<1> a hydroxy group,
<2> a C1-8 alkoxycarbonyl group,
<3> a 4- to 10-membered nitrogen-containing heterocycloalkylcarbonyl group which may be substituted by one or more R8E1,
<4> a (C1-8 alkyl)m8k1-amino group which may be substituted by one or more R8E2,
m8k1: 0˜2,
<5> a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R8E3,
<6> a 5- to 14-membered heteroaryl group,
<7> a (C1-8 alkyl)m8k2-aminocarbonyl group which may be substituted by one or more R8E6
m8k2: 0˜2,
<8> a C1-8 alkoxy group which may be substituted by one or more R8E7,
<9> a C1-8 alkylthio group,
<10> a C1-8 alkylsulfinyl group, or
<11> a C1-8 alkylsulfonyl group,
R8E1:
<1> a C1-8 alkoxycarbonyl group,
<2> a C1-8 alkanoyl group,
<3> a C1-8 alkylsulfonyl group,
<4> a (C1-8 alkyl)m8k3-aminosulfonyl group
m8k3: 0˜2, or
<5> a 4- to 10-membered heterocycloalkyl group,
R8E2:
<1> a hydroxy group,
<2> a C1-8 alkoxycarbonyl group,
<3> a C3-8 cycloalkyl group which may be substituted by C1-8 alkyl group(s) which may be substituted by hydroxy group(s),
<4> a C1-8 alkanoyl group which may be substituted by substituent(s) selected from the group consisting of [1] a (C1-8 alkyl)m8k4-amino group and [2] a halogen atom,
m8k4: 0˜2,
<5> a (C1-8 alkyl)m8k5-aminocarbonyl group,
m8k5: 0˜2,
<6> a C1-8 alkylsulfonyl group,
<7> a 4- to 10-membered nitrogen-containing heterocycloalkylsulfonyl group which may be substituted by C1-8 alkyl group(s),
<8> a (C1-8 alkyl)m8k6-aminosulfonyl group,
m8k6: 0˜2, or
R8E3:
<1> a C1-8 alkyl group which may be substituted by substituent(s) selected from the group consisting of [1] a hydroxy group and [2] a C1-8 alkylcarbonyloxy group,
<2> a hydroxy group,
<3> a C3-8 cycloalkyl group,
<4> a C1-8 alkylsulfonyl group,
<5> a (C1-8 alkyl)m8k8-aminocarbonyl group,
m8k8: 0˜2,
<6> a C1-8 alkanoyl group which may be substituted by hydroxy group(s),
<7> an oxo group, or
<8> a 4- to 10-membered heterocycloalkyl group which may be substituted by substituent(s) selected from the group consisting of [1] a C1-8 alkanoyl group, and [2] a C1-8 alkylsulfonyl group,
R8E6:
<1> a C2-8 alkenylcarbonyloxy group,
<2> a hydroxy group,
<3> a cyano group,
<4> a (C1-8 alkyl)m8k9-amino group which may be substituted by hydroxy group(s),
m8k9: 0˜2,
<5> a C1-8 alkoxy group which may be substituted by hydroxy group(s),
<6> a 4- to 10-membered heterocycloalkyl group which may be substituted by C1-8 alkyl group(s), or
<7> a 5- to 14-membered heteroaryl group,
R8E7:
<1> a hydroxy group, or
<2> a C1-8 alkoxy group which may be substituted by hydroxy group(s),
(15) a 4- to 10-membered heterocycloalkyloxy group which may be substituted by one or more R8F:
R8F:
<1> a C1-8 alkyl group which may be substituted by one or more R8F1,
<2> a C3-8 cycloalkyl group,
<3> a C1-8 alkanoyl group which may be substituted by halogen atom(s),
<4> a C1-8 alkoxycarbonyl group,
<5> a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R8F2,
<6> a C1-8 alkyl sulfonyl group, or
<7> a hydroxy group,
R8F1: [1] a hydroxy group, [2] a C1-8 alkoxy group, or [3] a halogen atom,
R8F2: [1] a 4- to 10-membered heterocycloalkyl group, [2] a C1-8 alkoxycarbonyl group, or [3] a C1-8 alkylsulfonyl group,
(16) a 5- to 14-membered heteroaryloxy group,
(17) a (C1-8 alkyl)m8l1-aminosulfonyloxy group,
m8l1: 0˜2,
(18) a C1-8 alkylthio group which may be substituted by (C1-8 alkyl) group(s),
m8l2: 0˜2,
(19) a C1-8 alkylsulfonyl group which may be substituted by one or more R8G,
R8G: [1] a hydroxycarbonyl group, [2] a hydroxy group, or [3] a (C1-8 alkyl)m8l3-amino group,
m8l3: 0˜2,
(20) a C2-8 alkenyloxy group, and
(21) a C1-8 alkylsulfonyloxy group which may be substituted by halogen atom(s);
R9 is selected from the group consisting of:
(1) a hydrogen atom,
(2) a C1-8 alkyl group which may be substituted by one or more R9A,
R9A: [1] a C3-8 cycloalkyl group, [2] a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R9A1, [3] a hydroxy group, or [4] a C1-8 alkoxy group,
R9A1: [1] a C1-8 alkyl group, [2] a C3-8 cycloalkyl group, or [3] a 4- to 10-membered heterocycloalkyl group,
(3) a C2-8 alkenyl group,
(4) a C2-8 alkynyl group which may be substituted by one or more R9C,
R9C: [1] a C1-8 alkoxy group, [2] a (C1-8 alkyl)m9b-amino group which may be substituted by C6-10 aryl group(s), [3] a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R9C1, [4] a C3-8 cycloalkyl group, [5] a hydroxy group, or [6] a hydroxycarbonyl group,
m9b: 0˜2,
R9C1: [1] a C3-8 cycloalkyl group, [2] a 4- to 10-membered heterocycloalkyl group, or [3] an oxo group,
(5) a C3-8 cycloalkyl group,
(6) a 4- to 10-membered heterocycloalkyl group which may be substituted by one or more R9D,
R9D: [1] a C1-8 alkyl group which may be substituted by 4- to 10-membered heterocycloalkyl group(s), [2] a C3-8 cycloalkyl group, [3] a 4- to 10-membered heterocycloalkyl group, or [4] a C1-6 alkylsulfonyl group,
(7) a C6-10 aryl group which may be substituted by one or more R9E,
R9E: [1] a halogen atom, [2] a hydroxy group, [3] a hydroxycarbonyl group, or [4] a C1-8 alkyl group which may be substituted by hydroxy group(s),
(8) a 5- to 14-membered heteroaryl group which may be substituted by C1-8 alkyl group(s),
(9) a cyano group,
(10) a C1-8 alkanoyl group,
(11) a 4- to 10-membered nitrogen-containing heterocycloalkylcarbonyl group which may be substituted by C1-8 alkyl group(s),
(12) a halogen atom,
(13) a (C1-8 alkyl)m9c-amino group,
m9c: 0˜2,
(14) a C1-8 alkylcarbonyl(C0-8 alkyl)amino group which may be substituted by (C1-8 alkyl)m9d-amino group(s),
m9d: 0˜2,
(15) a C1-8 alkylsulfonyl(C0-8 alkyl)amino group,
(16) a (C1-8 alkyl)m9c-aminosulfonyl(C0-8 alkyl)amino group,
m9e: 0˜2,
(17) a nitro group,
(18) a hydroxy group,
(19) a C1-8 alkoxy group which may be substituted by one or more R9G,
R9G: [1] a hydroxy group, [2] a hydroxycarbonyl group, [3] a C6-10 aryl group which may be substituted by C1-8 alkoxy group(s), [4] a (C1-8 alkyl)m9g1-amino group, [5] a C1-8 alkoxy group which may be substituted by one or more R9G1, or [6] a 5- to 14-membered heteroaryl group,
m9g1: 0˜2,
R9G1: [1] a C1-8 alkoxy group, or [2] a hydroxycarbonyl group,
(20) a 4- to 10-membered heterocycloalkyloxy group which may be substituted by 4- to 10-membered heterocycloalkyl group(s),
(21) a C1-8 alkylthio group which may be substituted by (C1-8 alkyl)m9f-amino group(s),
m9f: 0˜2,
(22) a C1-8 alkylsulfonyl group which may be substituted by (C1-8 alkyl)m9g-amino group(s),
m9g: 0˜2,
(23) a (C1-8 alkyl)m9h-aminosulfonyl group,
m9h: 0˜2, and
(24) a 4- to 10-membered nitrogen-containing heterocycloalkylsulfonyl group which may be substituted by C1-8 alkyl group(s);
R10 represents [1] a hydrogen atom, or [2] a 4- to 10-membered heterocycloalkyl group which may be substituted by 4- to 10-membered heterocycloalkyl group(s)].

### Claim 6

A compound or salt or solvate thereof, which said compound is selected from the group consisting of:
9-(4-isopropyl-piperazin-1-yl)-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-9-prop-1-ynyl-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
9-cyclopropylethynyl-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
6,6-dimethyl-8-(1-oxetan-3-yl-piperidin-4-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
9-bromo-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
9-bromo-8-(4-cyclopropyl-piperazin-1-yl)-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
9-chloro-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
8-(4-cyclobutyl-piperazin-1-yl)-6,6-dimethyl-11-oxo-9-prop-1-ynyl-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
6,6,9-trimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
9-ethyl-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
9-ethynyl-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
8-(4-cyclobutyl-piperazin-1-yl)-9-ethyl-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
9-ethynyl-6,6-dimethyl-11-oxo-8-(4-pyrrolidin-1-yl-piperidin-1-yl)-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
6,6-dimethyl-11-oxo-8-(4-pyrrolidin-1-yl-piperidin-1-yl)-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
8-(4-cyclobutyl-piperazin-1-yl)-9-ethynyl-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
8-(4-cyclobutyl-piperazin-1-yl)-6,6-dimethyl-11-oxo-9-propyl-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
8-(1-isopropyl-piperidin-4-yl)-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
8-(4-isopropyl-piperazin-1-yl)-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
8-(4-cyclobutyl-piperazin-1-yl)-9-cyclopropyl-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
8-(2-tert-butylamino-ethoxy)-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
9-ethynyl-8-(4-methanesulfonyl-piperazin-1-yl)-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
9-bromo-8-(4-cyclobutyl-piperazin-1-yl)-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile;
6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-9-propyl-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile; and
9-ethynyl-6,6-dimethyl-8-morpholin-4-yl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile.

### Claim 7 (depends on 1)

A medicament comprising as an active ingredient the compound according to claim 1, or a salt or solvate thereof.

### Claim 8 (depends on 1)

An ALK inhibitor comprising as an active ingredient the compound according to claim 1, or a salt or solvate thereof.

### Claim 9 (depends on 1)

A pharmaceutical for the prophylaxis or treatment of cancer, cancer metastasis, depression or cognitive function disorder, comprising as an active ingredient the compound according to claim 1, or a salt or solvate thereof.

### Claim 10 (depends on 1)

A pharmaceutical composition comprising the compound according to claim 1, or a salt or solvate thereof and a pharmaceutically acceptable carrier(s).
